Not applicableEnded earlyNCT00194415What this trial is testingHSV Testing Among Pregnant WomenWho this might be right forHerpes SimplexPregnancy University of Washington 173
Early research (Phase 1)Study completedNCT01950325What this trial is testingVRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...Who this might be right forHIV-1 InfectionNeutralizing AntibodyMonoclonal Antibody+2 more National Institute of Allergy and Infectious Diseases (NIAID) 27
Early research (Phase 1)Study completedNCT05791318What this trial is testingInvestigate the Safety, Tolerability, and Pharmacokinetics of the Monoclonal Antibody VYD222 in Healthy Adult ParticipantsWho this might be right forCOVID-19 Invivyd, Inc. 30
Not applicableStudy completedNCT05054582What this trial is testingCOVID-19 Antibody Responses In Cystic Fibrosis: CAR-CFWho this might be right forCystic FibrosisCovid19 Medical University Innsbruck 152
Not applicableUnknownNCT06274840What this trial is testingCOVID-19 Antibody Responses In Cystic FibrosisWho this might be right forCOVID-19Cystic Fibrosis Pilar Azevedo 1,000
Not applicableStudy completedNCT04916574What this trial is testingClinical Trial of BioBlock COVID-19 Nasal Spray Containing Anti-SARS-CoV-2 Antibodies Derived From Bovine ColostrumWho this might be right forSARS-COV2 InfectionCovid19 Icosagen Cell Factory 16
Testing effectiveness (Phase 2)UnknownNCT04133259What this trial is testingEvaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B PatientsWho this might be right forHepatitis B, Chronic Henlix, Inc 44
Not applicableStudy completedNCT04847388What this trial is testingPrevalence of Substance Abuse Among Anti-retroviral Treatment Naive Patients Positive for HIV AntibodiesWho this might be right forHIV Infections Singh, Ranjan Kumar, M.D. 210
Early research (Phase 1)Study completedNCT05291520What this trial is testingInvestigate the Safety and Pharmacokinetics of a Single Dose of VH3810109 (Also Known as GSK3810109), Administered Either Subcutaneously (SC) With rHuPH20 or Intravenously (IV), in Healthy Adult ParticipantsWho this might be right forHIV Infections ViiV Healthcare 24
Testing effectiveness (Phase 2)UnknownNCT04822376What this trial is testingProphylaxis Vaccine Antibodies EbolaWho this might be right forEbola Virus Disease ANRS, Emerging Infectious Diseases 250
Early research (Phase 1)Study completedNCT00503347What this trial is testingBavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency VirusWho this might be right forHepatitis C VirusHiv Infections Peregrine Pharmaceuticals 24
Not applicableStudy completedNCT01423643What this trial is testingHCV/HIV Coinfection: Antiviral Therapy and FibrosisWho this might be right forHIV InfectionHepatitis C Johns Hopkins University 1,250
Not applicableStudy completedNCT04841785What this trial is testingRECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease PatientsWho this might be right forCovid19SARS-CoV InfectionChronic Kidney Diseases University Medical Center Groningen 4,868
Early research (Phase 1)Study completedNCT03387150What this trial is testingEvaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered in Multiple Doses and Routes to Healthy, HIV-uninfected AdultsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 124
Not applicableLooking for participantsNCT04706390What this trial is testingComparison of the Immune Response to Natural COVID-19 Infection and VaccinationWho this might be right forCovid19 University of Bergen 2,500
Not applicableStudy completedNCT01447680What this trial is testingComparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody TestingWho this might be right forHuman Immunodeficiency Virus InfectionHepatitis C G & W Laboratories Inc. 1,600
Large-scale testing (Phase 3)Study completedNCT00291980What this trial is testingCompare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.Who this might be right forHepatitis B Henogen 185
Testing effectiveness (Phase 2)Study completedNCT04429854What this trial is testingDonated Antibodies Working Against nCoVWho this might be right forCOVID-19 Universitaire Ziekenhuizen KU Leuven 483
Not applicableStudy completedNCT04673279What this trial is testingLong-term COVID-19 Immune Response in a Vulnerable Neighbourhood in ArgentinaWho this might be right forCoronavirus Disease 2019 Hospital Italiano de Buenos Aires 189
Not applicableStudy completedNCT04779424What this trial is testingPrevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19)Who this might be right forSARS-CoV-2COVID-19 Universiteit Antwerpen 3,390